Active Shortage Injection Oncology

Carboplatin Injection · 1,243 days since initial FDA posting

Brand: CARBOPLATIN

FDA lists Carboplatin Injection as Active Shortage (Eugia US LLC).

Availability on file: Available

Carboplatin Injection: Active Shortage

Available Contact your pharmacist if you are affected.

Shortage Details

Generic Name
Carboplatin Injection
Manufacturer
Eugia US LLC
Dosage Form
Injection
Presentation
Carboplatin, Injection, 600 mg/60 mL (NDC 55150-386-01)
Package NDC
55150-386-01

Status & Timeline

Status
Active Shortage
Availability
Available
First Reported
Apr 28, 2023
Last Updated
Mar 6, 2026
Therapeutic Category
Oncology

Row fields from the FDA Drug Shortages database via openFDA.

Shortage Reason

Check wholesalers for inventory

Nearby, Other Carboplatin Shortage Records

Carboplatin Injection

Gland Pharma Limited

Injection

Active Shortage

Carboplatin Injection

Gland Pharma Limited

Injection

Active Shortage

Carboplatin Injection

Gland Pharma Limited

Injection

Active Shortage

Carboplatin Injection

Gland Pharma Limited

Injection

Active Shortage

Carboplatin Injection

Teyro Labs

Injection

Active Shortage

Carboplatin Injection

Teyro Labs

Injection

Active Shortage

FDA reason on file: Check wholesalers for inventory. General shortage guidance lives on the tracker hub.

← All Drug Shortages